What Azenta, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 2 |
| Sells | 0 | 0 |
| Total trades | 10 | 27 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 5,663 |
| Disposed | 0 | 0 |
| Net activity | +0 | +5,663 |
Common stock only — 26 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Madaus Martin D | Interim CEO | Oct 22 | Withheld — tax / exercise cost · F | −1,294 | $36.01 | −$46.6K | 41,308 |
| Madaus Martin D | Interim CEO | Sep 22 | Withheld — tax / exercise cost · F | −1,456 | $34.28 | −$49.9K | 42,602 |
| Bello Erik J. | VP Chief Accounting Officer | Sep 15 | Grant / award · A | +4,586 | — | — | 4,586 |
| Pirogova Olga | SVP and CHRO | Sep 14 | Grant / award · A | +15,272 | — | — | 47,225 |
| Madaus Martin D | Interim CEO | Sep 14 | Grant / award · A | +36,653 | — | — | 44,058 |
| Lin Lawrence Y. | EVP, CFO and Treasurer | Sep 14 | Grant / award · A | +30,544 | — | — | 110,199 |
| Martin William E. Iii | President Multiomics | Sep 14 | Grant / award · A | +15,272 | — | — | 33,062 |
| Starr Ephraim | SVP, Gen Counsel & Secretary | Sep 14 | Grant / award · A | +15,272 | — | — | 84,000 |
| Pirogova Olga | SVP and CHRO | Aug 09 | Withheld — tax / exercise cost · F | −1,085 | $32.04 | −$34.8K | 31,953 |
| Starr Ephraim | SVP, Gen Counsel & Secretary | Jul 31 | Open-market buy · P | +335 | $24.17 | +$8.1K | 68,728 |
| Cornog William L | Director | May 18 | Open-market buy · P | +10,000 | $16.38 | +$164K | 19,703 |
| Starr Ephraim | SVP, Gen Counsel & Secretary | May 15 | Withheld — tax / exercise cost · F | −3,621 | $16.02 | −$58K | 68,393 |
| Martin William E. Iii | President Multiomics | Apr 28 | Grant / award · A | +17,790 | $24.24 | +$431K | 17,790 |
| Nova Tina Susan | Director | Feb 06 | Grant / award · A | +5,663 | $27.85 | +$158K | 15,772 |
| McLaughlin Erica | Director | Feb 05 | Grant / award · A | +5,663 | $27.85 | +$158K | 22,521 |
| Casal Frank | Director | Feb 05 | Grant / award · A | +7,243 | $27.85 | +$202K | 21,803 |
| Koffey Quentin | Director | Feb 05 | Grant / award · A | +5,663 | — | — | 10,698 |
| Doshi Dipal | Director | Feb 05 | Grant / award · A | +5,663 | $27.85 | +$158K | 9,703 |
| Starr Ephraim | SVP, Gen Counsel & Secretary | Nov 24 | Grant / award · A | +34,235 | — | — | 72,014 |
| Pirogova Olga | SVP and CHRO | Nov 24 | Grant / award · A | +16,303 | — | — | 33,038 |
Loading...
